Search for:

United States


On 30 October 2023, President Biden issued a 63-page Executive Order to define the trajectory of artificial intelligence adoption, governance, and usage within the United States government. The Executive Order outlines eight guiding principles and priorities for US federal agencies to adhere to as they adopt, govern, and use AI. While safety and security are predictably high on the list, so too is a desire to make America a leader in the AI industry, including AI development by the federal government.

In the first three parts of this series, we provided an overview of the new US Food and Drug Administration regulatory requirements under the Modernization of Cosmetics Regulation Act of 2022 (MoCRA), the good manufacturing practices regulations FDA plans to establish, as well as the FDA draft guidance on the facility registrations and products listings. In this Part IV, we are providing an important update of FDA’s compliance policy – enforcement discretion for MoCRA facility registration and product listing until 1 July 2024, as well as the existing FDA resources to help industry prepare for MoCRA implementation.

During a LinkedIn Live session on 27 September 2023, IAPP Research and Insights Director Joe Jones discussed the latest regulatory law, policy and enforcement developments, and compliance considerations for children’s privacy in the EU, UK, and US with Baker McKenzie’s Elizabeth Denham, Lothar Determann and Jonathan Tam.

In first-of-its-kind legislation, under SB 54, California will require venture capital companies to collect and report diversity data from portfolio company founders as soon as 1 March 2025. The new Fair Investment Practices by Investment Advisers law intends to increase transparency regarding the diversity of founding teams receiving venture funds from covered entities in California.

Baker McKenzie’s Sanctions Blog published the alert titled US Government Publishes Compliance Note on Voluntary Self-Disclosures of Sanctions and Export Control Violations on 11 August 2023. Read the article via the link here. Please also visit our Sanctions Blog for the most recent updates.

On 8 August 2023, the US Department of the Treasury’s Office of Foreign Assets Control (OFAC) issued the OFAC Compliance Communique: Guidance for the Provision of Humanitarian Assistance to Syria. The guidance responds to specific questions that OFAC received from the non-governmental organization (NGO) community and the general public related to the provision of humanitarian assistance to the Syrian people. In addition, OFAC amended Frequently Asked Question 937 related to the Syria NGO general license.

On 9 August 2023, President Biden issued Executive Order 14105, targeting certain US investments into Chinese companies or Chinese-owned companies engaged in three advanced technology areas. The Executive Order directs the US Department of the Treasury to issue regulations that will (1) prohibit certain categories of US outbound investments and (2) require notification of other investments involving the People’s Republic of China, Hong Kong, and Macau

In the first part of this series, A Legal Makeover Guide for Complying with New Cosmetic Regulations under the Modernization of Cosmetic Regulation Act of 2022 (MoCRA) Part I, we provided an overview of the new US Food and Drug Administration (FDA) ‘s regulatory requirements for cosmetics and their implementation deadlines. In this second part, we will delve into the details and look at the good manufacturing practices regulations the FDA plans to establish for cosmetic products.

With the new Washington state My Health My Data Act, you may wonder if any exceptions or exemptions apply to your organization. As a reminder, the definition of consumer health data is broad: “personal information that is linked or reasonably linkable to a consumer and that identifies the consumer’s past, present, or future physical or mental health status.” Outside of the broad exclusion of employment context data, the My Health My Data Act’s list of exceptions and exemptions is long but is focused mainly on specific medical and health care contexts where health data is more narrowly defined or otherwise another specific law applying to processing of the data.